Andrew J Hung1, Jian Chen1, Saum Ghodoussipour1, Paul J Oh1, Zequn Liu2, Jessica Nguyen1, Sanjay Purushotham3, Inderbir S Gill1, Yan Liu4. 1. Center for Robotic Simulation and Education, USC Institute of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. 2. School of Electronics Engineering and Computer Science, Peking University, Beijing, China. 3. Department of Information Systems, University of Maryland, Baltimore, MD, USA. 4. Computer Science Department, Viterbi School of Engineering, University of Southern California, Los Angeles, CA, USA.
Abstract
OBJECTIVES: To predict urinary continence recovery after robot-assisted radical prostatectomy (RARP) using a deep learning (DL) model, which was then used to evaluate surgeon's historical patient outcomes. SUBJECTS AND METHODS: Robotic surgical automated performance metrics (APMs) during RARP, and patient clinicopathological and continence data were captured prospectively from 100 contemporary RARPs. We used a DL model (DeepSurv) to predict postoperative urinary continence. Model features were ranked based on their importance in prediction. We stratified eight surgeons based on the five top-ranked features. The top four surgeons were categorized in 'Group 1/APMs', while the remaining four were categorized in 'Group 2/APMs'. A separate historical cohort of RARPs (January 2015 to August 2016) performed by these two surgeon groups was then used for comparison. Concordance index (C-index) and mean absolute error (MAE) were used to measure the model's prediction performance. Outcomes of historical cases were compared using the Kruskal-Wallis, chi-squared and Fisher's exact tests. RESULTS: Continence was attained in 79 patients (79%) after a median of 126 days. The DL model achieved a C-index of 0.6 and an MAE of 85.9 in predicting continence. APMs were ranked higher by the model than clinicopathological features. In the historical cohort, patients in Group 1/APMs had superior rates of urinary continence at 3 and 6 months postoperatively (47.5 vs 36.7%, P = 0.034, and 68.3 vs 59.2%, P = 0.047, respectively). CONCLUSION: Using APMs and clinicopathological data, the DeepSurv DL model was able to predict continence after RARP. In this feasibility study, surgeons with more efficient APMs achieved higher continence rates at 3 and 6 months after RARP.
OBJECTIVES: To predict urinary continence recovery after robot-assisted radical prostatectomy (RARP) using a deep learning (DL) model, which was then used to evaluate surgeon's historical patient outcomes. SUBJECTS AND METHODS: Robotic surgical automated performance metrics (APMs) during RARP, and patient clinicopathological and continence data were captured prospectively from 100 contemporary RARPs. We used a DL model (DeepSurv) to predict postoperative urinary continence. Model features were ranked based on their importance in prediction. We stratified eight surgeons based on the five top-ranked features. The top four surgeons were categorized in 'Group 1/APMs', while the remaining four were categorized in 'Group 2/APMs'. A separate historical cohort of RARPs (January 2015 to August 2016) performed by these two surgeon groups was then used for comparison. Concordance index (C-index) and mean absolute error (MAE) were used to measure the model's prediction performance. Outcomes of historical cases were compared using the Kruskal-Wallis, chi-squared and Fisher's exact tests. RESULTS: Continence was attained in 79 patients (79%) after a median of 126 days. The DL model achieved a C-index of 0.6 and an MAE of 85.9 in predicting continence. APMs were ranked higher by the model than clinicopathological features. In the historical cohort, patients in Group 1/APMs had superior rates of urinary continence at 3 and 6 months postoperatively (47.5 vs 36.7%, P = 0.034, and 68.3 vs 59.2%, P = 0.047, respectively). CONCLUSION: Using APMs and clinicopathological data, the DeepSurv DL model was able to predict continence after RARP. In this feasibility study, surgeons with more efficient APMs achieved higher continence rates at 3 and 6 months after RARP.
Authors: Axel Heidenreich; Gunna Aus; Michel Bolla; Steven Joniau; Vsevolod B Matveev; Hans Peter Schmid; Filliberto Zattoni Journal: Actas Urol Esp Date: 2009-02 Impact factor: 0.994
Authors: Vincenzo Ficarra; Giacomo Novara; Raymond C Rosen; Walter Artibani; Peter R Carroll; Anthony Costello; Mani Menon; Francesco Montorsi; Vipul R Patel; Jens-Uwe Stolzenburg; Henk Van der Poel; Timothy G Wilson; Filiberto Zattoni; Alexandre Mottrie Journal: Eur Urol Date: 2012-06-01 Impact factor: 20.096
Authors: James W F Catto; Maysam F Abbod; Peter J Wild; Derek A Linkens; Christian Pilarsky; Ishtiaq Rehman; Derek J Rosario; Stefan Denzinger; Maximilian Burger; Robert Stoehr; Ruth Knuechel; Arndt Hartmann; Freddie C Hamdy Journal: Eur Urol Date: 2009-11-06 Impact factor: 20.096
Authors: Jessica H Nguyen; Jian Chen; Sandra P Marshall; Saum Ghodoussipour; Andrew Chen; Inderbir S Gill; Andrew J Hung Journal: World J Urol Date: 2019-07-25 Impact factor: 4.226
Authors: Daniel I Sanford; Balint Der; Taseen F Haque; Runzhuo Ma; Ryan Hakim; Jessica H Nguyen; Steven Cen; Andrew J Hung Journal: J Endourol Date: 2022-02 Impact factor: 2.942
Authors: B M Zeeshan Hameed; Aiswarya V L S Dhavileswarapu; Syed Zahid Raza; Hadis Karimi; Harneet Singh Khanuja; Dasharathraj K Shetty; Sufyan Ibrahim; Milap J Shah; Nithesh Naik; Rahul Paul; Bhavan Prasad Rai; Bhaskar K Somani Journal: J Clin Med Date: 2021-04-26 Impact factor: 4.241